Table 3 Prognostic variables for survival in 23 patients with CC
From: CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
Variables | Number of cases | Median survival in months (range) | Univariate analysis (P value) | Multivariate analysis (P value) |
|---|---|---|---|---|
Age | Â | Â | Â | Â |
< 60 | 14 | 14.00 (11.12-16.88) | 0.058 | 0.086 |
> 60 | 9 | 11 (3.82-18.21) | Â | Â |
Gender | Â | Â | Â | Â |
Male | 13 | 11 (7.15-14.85) | 0.005 | 0.116 |
Female | 10 | 17 (10.49-23.51) | Â | Â |
Differentiation status | Â | Â | Â | Â |
Well | 8 | 15 (12.8-17.1) | 0.025 | 0.010 |
Moderately | 6 | 8 (2.24-13.7) | Â | Â |
Poorly | 9 | 8 (0-19.7) | Â | Â |
Staging | Â | Â | Â | Â |
I/II | 6 | 14 (12.5-15.5) | 0.033 | 0.321 |
III/IV | 17 | 11 (4.9-17.1) | Â | Â |
CD133 expression | Â | Â | Â | Â |
Positive | 14 | 14 (11.9-16.1) | 0.001 | 0.007 |
Negative | 9 | 4 (0-8.2) | Â | Â |